Berberine Chloride

DRUG3 trials

Sponsors

National Cancer Institute (NCI), Jin-Kui Yang, Beijing Tongren Hospital

Conditions

Diabetes MellitusUlcerative Colitis

Early Phase 1

Berberine Hyperglycemic Clamp

CompletedNCT03972215

Jin-Kui YangDiabetes Mellitus

Start: 2019-10-01End: 2020-02-17Updated: 2023-07-10

Berberine on the Secretion of Incretin

CompletedNCT05947370

Beijing Tongren HospitalDiabetes Mellitus

Start: 2022-10-12End: 2023-04-20Updated: 2023-07-17

Phase 1

Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission

CompletedNCT02365480

National Cancer Institute (NCI)Ulcerative Colitis

Start: 2016-06-16End: 2019-12-13Updated: 2021-08-03

Related Papers

Berberine is an insulin secretagogue targeting the KCNH6 potassium channel.

2021-09-2379 citations